Tag: trebananib

Oral glucose tolerance test preferred for pre-diabetes screening in PCOS

The TRINOVA-1 trial: trebananib decreases progression of recurrent ovarian cancer

byDenise Pongand1 others

June 21, 2014

1. Ovarian cancer patients randomized to receive paclitaxel + trebananib had improved progression-free survival versus paclitaxel + placebo. 2. Patients ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Analysis of clinical outcomes utilizing ultrasound-assisted catheter-directed thrombolysis for pulmonary embolism
Ivonescimab improves survival in advanced non-small cell lung cancer
Utilization of an early-life risk factor score to determine later life type 2 diabetes risk

No Result

View All Result